Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 1
1951 1
1957 2
1958 1
1960 1
1962 1
1963 1
1966 1
1967 1
1968 3
1969 2
1970 5
1974 2
1975 3
1979 4
1980 2
1981 4
1982 4
1983 4
1985 1
1986 4
1987 1
1988 3
1989 7
1990 4
1991 3
1992 5
1993 6
1994 3
1995 3
1996 6
1997 6
1998 1
1999 4
2000 10
2001 3
2002 4
2003 12
2004 3
2005 5
2006 12
2007 9
2008 15
2009 13
2010 4
2011 14
2012 14
2013 18
2014 16
2015 21
2016 18
2017 21
2018 19
2019 20
2020 32
2021 41
2022 22
2023 23
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

426 results

Results by year

Filters applied: . Clear all
Page 1
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775. N Engl J Med. 2018. PMID: 30575490 Clinical Trial.
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.
Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A, Kuruvilla P, Hill D, Spadafora S, Marquis K, Trinkaus M, Tomiak A, Lee AYY, Gross PL, Lazo-Langner A, El-Maraghi R, Goss G, Le Gal G, Stewart D, Ramsay T, Rodger M, Witham D, Wells PS; AVERT Investigators. Carrier M, et al. N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4. N Engl J Med. 2019. PMID: 30511879 Clinical Trial.
Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities.
Magnani CF, Gaipa G, Lussana F, Belotti D, Gritti G, Napolitano S, Matera G, Cabiati B, Buracchi C, Borleri G, Fazio G, Zaninelli S, Tettamanti S, Cesana S, Colombo V, Quaroni M, Cazzaniga G, Rovelli A, Biagi E, Galimberti S, Calabria A, Benedicenti F, Montini E, Ferrari S, Introna M, Balduzzi A, Valsecchi MG, Dastoli G, Rambaldi A, Biondi A. Magnani CF, et al. J Clin Invest. 2020 Nov 2;130(11):6021-6033. doi: 10.1172/JCI138473. J Clin Invest. 2020. PMID: 32780725 Free PMC article. Clinical Trial.
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
Sangro B, Chan SL, Kelley RK, Lau G, Kudo M, Sukeepaisarnjaroen W, Yarchoan M, De Toni EN, Furuse J, Kang YK, Galle PR, Rimassa L, Heurgué A, Tam VC, Van Dao T, Thungappa SC, Breder V, Ostapenko Y, Reig M, Makowsky M, Paskow MJ, Gupta C, Kurland JF, Negro A, Abou-Alfa GK; HIMALAYA investigators. Sangro B, et al. Ann Oncol. 2024 Feb 19:S0923-7534(24)00049-8. doi: 10.1016/j.annonc.2024.02.005. Online ahead of print. Ann Oncol. 2024. PMID: 38382875 Free article.
Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma.
Ma LX, Wang Y, Espin-Garcia O, Allen MJ, Jang GH, Zhang A, Dodd A, Ramotar S, Hutchinson S, Tehfe M, Ramjeesingh R, Biagi J, Wilson JM, Notta F, Fischer SE, Zogopoulos G, Gallinger S, Grant RC, Khokha R, Chan N, Grünwald BT, Knox JJ, O'Kane GM. Ma LX, et al. Br J Cancer. 2023 May;128(10):1916-1921. doi: 10.1038/s41416-023-02214-0. Epub 2023 Mar 16. Br J Cancer. 2023. PMID: 36927977 Free PMC article.
HLA-DQ7.5 and coeliac disease.
Maimaris S, Schiepatti A, Scarcella C, Badulli C, Biagi F. Maimaris S, et al. Int J Immunogenet. 2024 Apr 9. doi: 10.1111/iji.12671. Online ahead of print. Int J Immunogenet. 2024. PMID: 38594883 No abstract available.
Combined DFT, SCAPS-1D, and wxAMPS frameworks for design optimization of efficient Cs(2)BiAgI(6)-based perovskite solar cells with different charge transport layers.
Hossain MK, Arnab AA, Das RC, Hossain KM, Rubel MHK, Rahman MF, Bencherif H, Emetere ME, Mohammed MKA, Pandey R. Hossain MK, et al. RSC Adv. 2022 Dec 7;12(54):34850-34873. doi: 10.1039/d2ra06734j. eCollection 2022 Dec 6. RSC Adv. 2022. PMID: 36540224 Free PMC article.
In this study, combined DFT, SCAPS-1D, and wxAMPS frameworks are used to investigate the optimized designs of Cs(2)BiAgI(6) double perovskite-based solar cells. First-principles calculations are employed to investigate the structural stability, optical responses, and elect …
In this study, combined DFT, SCAPS-1D, and wxAMPS frameworks are used to investigate the optimized designs of Cs(2)BiAgI(6) double pe …
426 results